{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:40:58Z","timestamp":1792428058819,"version":"4.5.0"},"reference-count":44,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Buddhist Tzu Chi Medical Foundation","award":["TCMF-SP-112-01"],"award-info":[{"award-number":["TCMF-SP-112-01"]}]},{"name":"Buddhist Tzu Chi Medical Foundation","award":["TCMF-MP-110-03-01"],"award-info":[{"award-number":["TCMF-MP-110-03-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>To analyze the urinary biomarkers in men with lower urinary-tract symptoms (LUTS) and identify interstitial cystitis\/bladder pain syndrome (IC\/BPS) from the other lower urinary-tract dysfunctions (LUTDs) by the levels of characteristic urinary biomarkers. In total, 198 men with LUTS were prospectively enrolled and urine samples were collected before intervention or medical treatment. Videourodynamic studies were routinely performed and the LUTDs were diagnosed as having bladder-outlet obstruction (BOO) such as bladder-neck dysfunction, benign prostatic obstruction, or poor relaxation of external sphincter (PRES); and bladder dysfunction such as detrusor overactivity (DO), hypersensitive bladder (HSB), and IC\/BPS. Patients suspicious of IC\/BPS were further confirmed by cystoscopic hydrodistention under anesthesia. The urine samples were investigated for 11 urinary inflammatory biomarkers including eotaxin, IL-6, IL-8, CXCL10, MCP-1, MIP-1\u03b2, RANTES, TNF-\u03b1, NGF, BDNF, and PGE2; and 3 oxidative stress biomarkers 8-OHdG, 8-isoprostane, and TAC. The urinary biomarker levels were analyzed between LUTD subgroups and IC\/BPS patients. The results of this study revealed that among the patients, IC\/BPS was diagnosed in 48, BOO in 66, DO in 25, HSB in 27, PRES in 15, and normal in 17. Patients with BOO had a higher detrusor pressure and BOO index than IC\/BPS, whereas patients with IC\/BPS, BOO, and DO had a smaller cystometric bladder capacity than the PRES and normal subgroups. Among the urinary biomarkers, patients with IC\/BPS had significantly higher levels of eotaxin, MCP-1, TNF-\u03b1, 8-OHdG, and TAC than all other LUTD subgroups. By a combination of different characteristic urinary biomarkers, TNF-\u03b1, and eotaxin, either alone or in combination, had the highest sensitivity, specificity, positive predictive value, and negative predictive value to discriminate IC\/BPS from patients of all other LUTD subgroups, BOO, DO, or HSB subgroups. Inflammatory biomarker MCP-1 and oxidative stress biomarkers 8-OHdG and TAC, although significantly higher in IC\/BPS than normal and PRES subgroups, did not have a diagnostic value between male patients with IC\/BPS and the BOO, DO, or HSB subgroups. The study concluded that using urinary TNF-\u03b1 and eotaxin levels, either alone or in combination, can be used as biomarkers to discriminate patients with IC\/BPS from the other LUTD subgroups in men with LUTS.<\/jats:p>","DOI":"10.3390\/ijms241512055","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T01:51:47Z","timestamp":1690509107000},"page":"12055","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Use of Urinary Biomarkers in Discriminating Interstitial Cystitis\/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions"],"prefix":"10.3390","volume":"24","author":[{"given":"Wan-Ru","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Nursing, Hualien Tzu Chi Hospital, Buddhist Tzu Chi General Hospital, Hualien 970, Taiwan"},{"name":"Institute of Medical Sciences, Tzu Chi University, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7870-1574","authenticated-orcid":false,"given":"Yuan-Hong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital and Tzu Chi University, Buddhist Tzu Chi Medical Foundation, 707, Section 3, Chung Yang Road, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Fong","family":"Jhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital and Tzu Chi University, Buddhist Tzu Chi Medical Foundation, 707, Section 3, Chung Yang Road, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-4771","authenticated-orcid":false,"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital and Tzu Chi University, Buddhist Tzu Chi Medical Foundation, 707, Section 3, Chung Yang Road, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","article-title":"How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study","volume":"87","author":"Milsom","year":"2001","journal-title":"BJU Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association","volume":"148","author":"Barry","year":"1992","journal-title":"J. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/luts.12139","article-title":"Role of Bladder Dysfunction in Men with Lower Urinary Tract Symptoms Refractory to Alpha-blocker Therapy: A Video-urodynamic Analysis","volume":"10","author":"Jiang","year":"2018","journal-title":"Low Urin. Tract Symptoms"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.urology.2007.03.063","article-title":"Videourodynamic analysis of pathophysiology of men with both storage and voiding lower urinary tract symptoms","volume":"70","author":"Kuo","year":"2007","journal-title":"Urology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s11255-022-03294-2","article-title":"Clinical presentation, videourodynamic characteristics, and treatment outcome in men with interstitial cystitis-like lower urinary tract symptoms","volume":"54","author":"Yu","year":"2022","journal-title":"Int. Urol. Nephrol."},{"key":"ref_6","first-page":"72","article-title":"Recent research on the role of urodynamic study in the diagnosis and treatment of male lower urinary tract symptoms and urinary incontinence","volume":"29","author":"Jiang","year":"2017","journal-title":"Ci Ji Yi Xue Za Zhi"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Jiang, Y.H., Wang, C.C., and Kuo, H.C. (2018). Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0190704"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/nau.23903","article-title":"International Consultation on Incontinence 2016, Executive summary: Urodynamic testing","volume":"38","author":"Rosier","year":"2019","journal-title":"Neurourol. Urodyn."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.juro.2006.03.089","article-title":"Prevalence of prostatitis-like symptoms in a managed care population","volume":"176","author":"Clemens","year":"2006","journal-title":"J. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","article-title":"Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment","volume":"193","author":"Hanno","year":"2015","journal-title":"J. Urol."},{"key":"ref_11","first-page":"668","article-title":"The enigma of men with interstitial cystitis\/bladder pain syndrome","volume":"4","author":"Arora","year":"2015","journal-title":"Trans. Androl. Urol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/pcan.2008.42","article-title":"Clinical phenotyping in chronic prostatitis\/chronic pelvic pain syndrome and interstitial cystitis: A management strategy for urologic chronic pelvic pain syndromes","volume":"12","author":"Shoskes","year":"2009","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0090-4295(01)01121-9","article-title":"Observations on the presentation, diagnosis, and treatment of interstitial cystitis in men","volume":"57","author":"Forrest","year":"2001","journal-title":"Urology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/iju.14234","article-title":"Clinical guidelines for interstitial cystitis\/bladder pain syndrome","volume":"27","author":"Homma","year":"2020","journal-title":"Int. J. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"F603","DOI":"10.1152\/ajprenal.00128.2017","article-title":"Bladder fibrosis during outlet obstruction is triggered through the NLRP3 inflammasome and the production of IL-1\u03b2","volume":"313","author":"Hughes","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Miyata, Y., Matsuo, T., Mitsunari, K., Asai, A., Ohba, K., and Sakai, H.A. (2019). Review of Oxidative Stress and Urinary Dysfunction Caused by Bladder Outlet Obstruction and Treatments Using Antioxidants. Antioxidants, 8.","DOI":"10.3390\/antiox8050132"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"F1103","DOI":"10.1152\/ajprenal.00058.2019","article-title":"Functional changes in low- and high-threshold afferents in obstruction-induced bladder overactivity","volume":"316","author":"Zagorodnyuk","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.23736\/S2724-6051.21.04308-1","article-title":"Renal surgery for kidney cancer: Is preoperative proteinuria a predictor of functional and survival outcomes after surgery? A systematic review of the literature","volume":"74","author":"Flammia","year":"2022","journal-title":"Minerva Urol. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11934-022-01098-6","article-title":"The Use of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Diagnostic and Prognostic Biomarker in Urinary Tract Obstruction: A Systematic Review","volume":"23","author":"Brewin","year":"2022","journal-title":"Curr. Urol. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s11255-020-02537-4","article-title":"Urinary biomarkers of inflammation and tissue remodeling may predict bladder dysfunction in patients with benign prostatic hyperplasia","volume":"52","author":"Barbosa","year":"2020","journal-title":"Int. Urol. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.euf.2019.06.006","article-title":"Urinary Biomarkers in Overactive Bladder: Revisiting the Evidence in 2019","volume":"5","author":"Cruz","year":"2019","journal-title":"Eur. Urol. Focus"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1442-2042.2005.01140.x","article-title":"Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom","volume":"12","author":"Kim","year":"2005","journal-title":"Int. J. Urol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Jiang, Y.H., Jhang, J.F., Hsu, Y.H., and Kuo, H.C. (2022). Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis\/Bladder Pain Syndrome. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231912044"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yu, W.R., Jiang, Y.H., Jhang, J.F., and Kuo, H.C. (2022). Use of Urinary Cytokine and Chemokine Levels for Identifying Bladder Conditions and Predicting Treatment Outcomes in Patients with Interstitial Cystitis\/Bladder Pain Syndrome. Biomedicines, 10.","DOI":"10.3390\/biomedicines10051149"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Jiang, Y.H., Jhang, J.F., Ho, H.C., Chiou, D.Y., and Kuo, H.C. (2022). Urine Oxidative Stress Biomarkers as Novel Biomarkers in Interstitial Cystitis\/Bladder Pain Syndrome. Biomedicines, 10.","DOI":"10.3390\/biomedicines10071701"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrurol.2016.249","article-title":"New insights into interstitial cystitis and chronic pelvic pain syndromes","volume":"14","author":"Jhang","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.urology.2014.04.044","article-title":"Association between postoperative pelvic anatomic features on magnetic resonance imaging and lower tract urinary symptoms after radical prostatectomy","volume":"84","author":"Haga","year":"2014","journal-title":"Urology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1097\/01.ju.0000145102.40773.43","article-title":"Interstitial cystitis, chronic nonbacterial prostatitis and chronic pelvic pain syndrome in men: A common and frequently identical clinical entity","volume":"172","author":"Forrest","year":"2004","journal-title":"J. Urol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.ju.0000131592.98562.16","article-title":"Failure of a monotherapy strategy for difficult chronic prostatitis\/chronic pelvic pain syndrome","volume":"172","author":"Nickel","year":"2004","journal-title":"J. Urol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"F1391","DOI":"10.1152\/ajprenal.00051.2020","article-title":"Urine cytokines as biomarkers for diagnosing interstitial cystitis\/bladder pain syndrome and mapping its clinical characteristics","volume":"318","author":"Jiang","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41598-020-80131-5","article-title":"Urine biomarkers in ESSIC type 2 interstitial cystitis\/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm","volume":"11","author":"Jiang","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.1038\/s41598-022-10696-w","article-title":"Diagnostic and prognostic value of urine biomarkers among women with dysfunctional voiding","volume":"12","author":"Jiang","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Jiang, Y.H., Jhang, J.F., and Kuo, H.C. (2022). Can We Use Urinary Cytokine\/Chemokine Analysis in Discriminating Ulcer-Type Interstitial Cystitis\/Bladder Pain Syndrome?. Diagnostics, 12.","DOI":"10.3390\/diagnostics12051093"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Chen, W.H., Jiang, Y.H., and Kuo, H.C. (2023). Urinary Oxidative Stress Biomarkers in the Diagnosis of Detrusor Overactivity in Female Patients with Stress Urinary Incontinence. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020357"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"F36","DOI":"10.1152\/ajprenal.00075.2017","article-title":"A MAPP Network study: Overexpression of tumor necrosis factor-alpha in mouse urothelium mimics interstitial cystitis","volume":"315","author":"Yang","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Lin, H.Y., Lu, J.H., Chuang, S.M., Chueh, K.S., Juan, T.J., Liu, Y.C., and Juan, Y.S. (2021). Urinary biomarkers in interstitial cystitis\/bladder pain syndrome and its impact on therapeutic outcome. Diagnostics, 12.","DOI":"10.3390\/diagnostics12010075"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/iju.12311","article-title":"Potential urine and serum biomarkers for patients with bladder pain syndrome\/interstitial cystitis","volume":"21","author":"Kuo","year":"2014","journal-title":"Int. J. Urol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.urology.2007.02.067","article-title":"Prevalence of pelvic floor dysfunction in patients with interstitial cystitis","volume":"70","author":"Peters","year":"2007","journal-title":"Urology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/nau.23897","article-title":"The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction","volume":"38","author":"Haylen","year":"2019","journal-title":"Neurourol. Urodyn."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/S0022-5347(01)63178-1","article-title":"The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis","volume":"159","author":"Parsons","year":"1998","journal-title":"J. Urol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41598-020-80252-x","article-title":"Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment","volume":"11","author":"Yu","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2007.09.019","article-title":"Diagnostic criteria, classification, and nomenclature for painful bladder syndrome\/interstitial cystitis: An ESSIC proposal","volume":"53","author":"Nordling","year":"2008","journal-title":"Eur. Urol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0090-4295(01)01112-8","article-title":"Clinical highlights of the National Institute of Diabetes and Digestive and Kidney Diseases\/Interstitial Cystitis Association scientific conference on interstitial cystitis","volume":"57","author":"Hanno","year":"2001","journal-title":"Urology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s11255-017-1666-z","article-title":"Urinary biomarkers in patients with detrusor underactivity with and without bladder function recovery","volume":"49","author":"Chen","year":"2017","journal-title":"Int. Urol. Nephrol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/15\/12055\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:20:50Z","timestamp":1760127650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/15\/12055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":44,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["ijms241512055"],"URL":"https:\/\/doi.org\/10.3390\/ijms241512055","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]}}}